Cargando…
Corrigendum: The Contribution of Serum Complement Component 3 Levels to 90-Day Mortality in Living Donor Liver Transplantation
Autores principales: | Fukui, Saeko, Hidaka, Masaaki, Fukui, Shoichi, Morimoto, Shimpei, Hara, Takanobu, Soyama, Akihiko, Adachi, Tomohiko, Matsushima, Hajime, Tanaka, Takayuki, Fuchigami, Mai, Hasegawa, Hiroo, Yanagihara, Katsunori, Eguchi, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004469/ https://www.ncbi.nlm.nih.gov/pubmed/35422811 http://dx.doi.org/10.3389/fimmu.2022.870480 |
Ejemplares similares
-
The Contribution of Serum Complement Component 3 Levels to 90-Day Mortality in Living Donor Liver Transplantation
por: Fukui, Saeko, et al.
Publicado: (2021) -
Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature
por: Eguchi, Susumu, et al.
Publicado: (2022) -
Management of Spontaneous Portosystemic Shunts in 231 Patients Who Underwent Living Donor Liver Transplantation: A Retrospective Study from a Single Center in Nagasaki, Japan
por: Hamada, Takashi, et al.
Publicado: (2022) -
Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosis
por: Nagakawa, Kantoku, et al.
Publicado: (2023) -
Long‐term outcomes of living‐donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3‐cm nodules in a single institute
por: Hidaka, Masaaki, et al.
Publicado: (2022)